Joey Trantham, MD
Clinical Cardiac Electrophysiology · Panama City, FLNPI 1497774087
Payments from drug & device makers
Across 259 payments — averaging $163.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$22K
- Johnson & Johnson$14K
- Medical Device Business Services, Inc.$2K
- Novartis$449
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$409
- Boston Scientific$384
- plus $3K from 27 others
What the payments were for
- Speaking & faculty fees$12,20055%
- Travel & lodging$4,09618%
- Food & beverage$5,86726%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 25 | $22,157 |
| Johnson & Johnson | 31 | $14,005 |
| Medical Device Business Services, Inc. | 19 | $2,331 |
| Novartis | 35 | $449 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $409 |
| Boston Scientific | 8 | $384 |
| Amgen | 18 | $322 |
| E.r. Squibb & Sons, L.L.C. | 17 | $290 |
| Merck | 20 | $268 |
| Sanofi-aventis U.S. LLC | 8 | $258 |
| Boehringer Ingelheim | 8 | $181 |
| Amarin Pharma, Inc. | 8 | $173 |
| Chiesi USA, Inc. | 6 | $150 |
| Recor Medical Inc | 1 | $136 |
| AstraZeneca | 8 | $117 |
| Abbott | 3 | $103 |
| Bayer | 5 | $103 |
| Biosense Webster, Inc. | 3 | $87 |
| Alnylam Pharmaceuticals Inc. | 3 | $66 |
| Philips North America LLC | 2 | $64 |
| Opsens Inc. | 1 | $49 |
| Pfizer | 3 | $46 |
| Cardiovascular Systems Inc. | 3 | $39 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| Shockwave Medical, Inc | 1 | $26 |
| Siemens Medical Solutions USA, Inc. | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Scpharmaceuticals Inc. | 1 | $21 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Bardy Diagnostics, Inc. | 1 | $12 |
| Cvrx, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$13,478
- Carto 3 System$1,837
- EMBLEM$199
- Paradise Ultrasound Renal Denervation System$136
- AZURE XT DR MRI SURESCAN$126
- SYMPLICITY G3$118
- Micra$116
- Reveal LINQ$109
- MULTAQ$108
- CROME DR MRI SURESCAN$101
- Advisa$101
How this compares
$42,391 in reported general payments places this provider in the 55th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 92 | $114,552 |
| EliquisApixaban | 74 | $104,441 |
| XareltoRivaroxaban | 71 | $87,638 |
| VerquvoVericiguat | 11 | $11,206 |
| Carvedilol ErCarvedilol Phosphate | 12 | $3,559 |
| Carvedilol | 309 | $2,976 |
| Digoxin | 105 | $2,716 |
| Losartan Potassium | 57 | $1,017 |
| ClopidogrelClopidogrel Bisulfate | 50 | $910 |
| Enalapril Maleate | 31 | $757 |
| Amlodipine Besylate | 54 | $571 |
| Atorvastatin Calcium | 34 | $355 |
| Pravastatin Sodium | 26 | $334 |
| Metoprolol Succinate | 32 | $328 |
| Metoprolol Tartrate | 11 | $318 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $449 | $114,55292 claims |
| PfizerEliquis | $46 | $104,44174 claims |
| Johnson & JohnsonXarelto | $14,005 | $87,63871 claims |
| MerckVerquvo | $268 | $11,20611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Panama City
- Nghia HoangPanama City$174K
- Jose Osorio FilhoMiami$16.4M
- Saumil OzaJacksonville$4.1M
- Usman SiddiquiWinter Park$3.6M
- David KenigsbergFort Lauderdale$1.3M
- Venkata SagiJacksonville$1.2M
- Raul WeissMiami Beach$1.1M
- Robert FishelAtlantis$1.1M
- Naushad ShaikKissimmee$1.1M
- Neal KaveshLakeland$967K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.